Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE SALEUR : revenue, balance sheet and financial ratios

SELARL PHARMACIE SALEUR is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SETE (34200), this company of category PME shows in 2025 a net income positive of 6 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE SALEUR (SIREN 522120658)
Kennzahl 2025 2024 2023 2022 2021 2020 2019
Umsatz N/C N/C N/C N/C N/C N/C N/C
Nettoergebnis 5 750 € 17 230 € 4 285 € 151 077 € 168 770 € 115 094 € 147 054 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, SELARL PHARMACIE SALEUR generates positive net income of 6 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 147 k€ -> 6 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

5 750 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 52%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

51.534%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

62.133%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

45.6%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE SALEUR

Positionnement sectoriel

Debt ratio
51.53 2025
2023
2024
2025
Q1: 13.7
Méd: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of SELARL PHARMACIE SALEUR (51.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
62.13% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.72%
Q3: 72.08%
Good +6 pts über 3 Jahre

In 2025, the financial autonomy of SELARL PHARMACIE SALEUR (62.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 461.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

461.906

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE SALEUR

Positionnement sectoriel

Liquidity ratio
461.91 2025
2023
2024
2025
Q1: 131.03
Méd: 182.25
Q3: 258.64
Excellent

In 2025, the liquidity ratio of SELARL PHARMACIE SALEUR (461.91) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positionnement de SELARL PHARMACIE SALEUR dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE SALEUR is estimated at 91 339 € (range 61 983€ - 143 324€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
61k€ 91k€ 143k€
91 339 € Range: 61 983€ - 143 324€
NAF 5 année 2025

Valuation method used

Net Income Multiple
5 750 € × 15.9x = 91 339 €
Range: 61 983€ - 143 324€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE SALEUR with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE SALEUR

What is the revenue of SELARL PHARMACIE SALEUR ?

The revenue of SELARL PHARMACIE SALEUR is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE SALEUR profitable?

Yes, SELARL PHARMACIE SALEUR generated a net profit of 6 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE SALEUR ?

The headquarters of SELARL PHARMACIE SALEUR is located in SETE (34200), in the department Herault.

Where to find the tax return of SELARL PHARMACIE SALEUR ?

The tax return of SELARL PHARMACIE SALEUR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE SALEUR operate?

SELARL PHARMACIE SALEUR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.